These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7521072)

  • 21. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo.
    Gries A; Bode C; Peter K; Herr A; Böhrer H; Motsch J; Martin E
    Circulation; 1998 Apr; 97(15):1481-7. PubMed ID: 9576429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in platelet aggregation caused by glyburide in diabetic patients.
    De Bellis R; Novoa E; Dol B; Cazerez J; Arroyo G; Balbela B; Navarro A
    Clin Ther; 1984; 6(3):335-43. PubMed ID: 6426797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of procainamide on rabbit platelet aggregation and thromboxane B2 production in vitro.
    Shan CW; Lin JH; Jin YH
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):164-6. PubMed ID: 10374644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propofol inhibits in vitro platelet aggregation in human whole blood.
    De La Cruz JP; Carmona JA; Paez MV; Blanco E; Sanchez De La Cuesta F
    Anesth Analg; 1997 Apr; 84(4):919-21. PubMed ID: 9085982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of platelet aggregation by cigarette smoke and carbon monoxide.
    Mansouri A; Perry CA
    Thromb Haemost; 1982 Dec; 48(3):286-8. PubMed ID: 7164019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin enhances platelet aggregation induced by adenosine diphosphate in vitro.
    Wu Q; Huang KS; Chen M; Huang DJ
    Platelets; 2009 Sep; 20(6):428-31. PubMed ID: 19639515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of oral ketotifen on ex vivo platelet activating factor-induced platelet aggregation.
    Saeed SA; Mahmood F; Naqvi A; Jafary MH
    Agents Actions Suppl; 1991; 34():351-7. PubMed ID: 1793071
    [No Abstract]   [Full Text] [Related]  

  • 28. Pluronic F-68 inhibits agonist-induced platelet aggregation in human whole blood in vitro.
    Edwards CM; Heptinstall S; Lowe KC
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):441-7. PubMed ID: 9844710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial inhibition of human neutrophil activation by FK-506 at supratherapeutic concentrations.
    Wenzel-Seifert K; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):7-13. PubMed ID: 7690907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of immunosuppressive drugs on platelet aggregation in vitro.
    Małyszko J; Małyszko JS; Takada A; Myśliwiec M
    Ann Transplant; 2002; 7(1):55-68. PubMed ID: 12221905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pentoxifylline on platelet aggregation.
    Nenci GG; Gresele P; Agnelli G; Ballatori E
    Pharmatherapeutica; 1981; 2(8):532-8. PubMed ID: 7255510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose aspirin inhibits arachidonic acid-precipitated platelet aggregation but not collagen-precipitated platelet aggregation.
    Roehm E
    Am J Cardiol; 1995 Sep; 76(8):637-8. PubMed ID: 7677099
    [No Abstract]   [Full Text] [Related]  

  • 33. Different effects of furosemide on alpha-adrenoceptors and on platelet aggregation in man.
    Kribben A; Fritschka E; Sibold M; Fassbender M; Rothschild M; Distler A; Philipp T
    Klin Wochenschr; 1988 Jul; 66(14):624-7. PubMed ID: 2850406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the extract from Conyza canadensis on human blood platelet aggregation.
    Saluk-Juszczak J; Olas B; Pawlaczyk I; Gancarz R; Wachowicz B
    Gen Physiol Biophys; 2007 Jun; 26(2):150-2. PubMed ID: 17660590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation.
    Wadenvik H; Kutti J
    Acta Haematol; 1985; 73(4):224-7. PubMed ID: 2414956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influences of 3,4,5-trihydroxystibene-3-beta-mono-D-glucoside on rabbits' platelet aggregation and thromboxane B2 production in vitro].
    Shan CW; Yang SQ; He HD; Shao SL; Zhang PW
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):527-30. PubMed ID: 2130618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations.
    Kung L; Halloran PF
    Transplantation; 2000 Jul; 70(2):327-35. PubMed ID: 10933159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropeptide Y and platelet aggregation by adrenaline.
    Dewar HA; Zar MA; Oxley A
    Life Sci; 1989; 45(5):367-70. PubMed ID: 2770405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of propranolol and 4-hydroxypropranolol on platelet aggregation and thromboxane A2 generation.
    Mehta J; Mehta P; Ostrowski N
    Clin Pharmacol Ther; 1983 Nov; 34(5):559-64. PubMed ID: 6627818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.